毅嘉管理顧問股份有限公司
Update：2026/11/10
Industries
Main Industry
Professional Services
Main Product/Service
Definition of prodrug: Use chemical engineering methods that connect an existing drug with a promoiety to form a prodrug.
The prodrug technology we developed can resolve developmental barriers of certain drug candidates; such as solubility, chemical stabi
The prodrug technology we developed can resolve developmental barriers of certain drug candidates; such as solubility, chemical stabi
The content above was translated by Ai
Founded Year
2019
Unified Business No.
54996030
Status
Closed
Number of Employees
0
Total Paid-in
Capital
1,000,000 (NT$)
Location of Company
Taiwan
, Tainan City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BoYen Therapeutics Inc. was established in June 2010. In its early years BoYen Therapeutics focused on new drug research and discovery, through our own proprietary prodrug technology platform, we perform chemosynthesis modification and create new patentab
The content above was translated by Ai
